Products and Services
-
Scottish nebulizer developer Nebu-Flow has raised £1.7 million “to continue the commercialization and delivery of next generation respiratory pharmaceuticals,” the company has announced on social media. The funding round was led by Foresight Williams Technology.… Read more . . .
-
Zeteo Biomedical has announced the launch of its ZEOx1 OrionMRQ metered dose nasal device for delivery of drugs and vaccines. Zeteo’s ZEOx1 devices are designed for intranasal delivery of liquid formulations, and its ZEOx2 devices… Read more . . .
-
DPI developer Iconovo has announced that Galenica AB will offer cGMP manufacturing of Iconovo’s ICOone single dose disposable DPI for clinical trials, so that customers wanting to develop an inhaled drug delivered by the ICOone… Read more . . .
-
Proveris Scientific has named Ramesh Chand as Associate Director of Proveris Laboratories, the company’s contract testing business, which launched in May 2020. Chand was most recently Principal Scientist in Respiratory Drug Product Development at Moderna and previously held… Read more . . .
-
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, has announced that it will acquire inhaled drug CRO iPharma Labs, and iPharma’s team of well-known OINDP specialists will join Kindeva. Founded in 2016, iPharma extended its… Read more . . .
-
Copley Scientific has announced the launch of the Gentle Rocker 100i device for faster sample recovery from the Next Generation Impactor (NGI). According to Copley, the Gentle Rocker 100i offers controlled agitation of the entire… Read more . . .
-
CDMO Catalent, which offers services for a full range of OINDPs, has announced the completion of the first phase of “a significant expansion” of its development and manufacturing capabilities for unit dose and bi-dose nasal… Read more . . .
-
CDMO Recipharm said that it is now offering services for reformulation of MDIs with new lower global warming potential propellants such as HFA 152a and HFO 1234ze. The company also announced that it has partnered… Read more . . .
-
Inhalation API manufacturer Inke has announced a €9 million expansion of its manufacturing facility in Castellbisbal, Barcelona, Spain “to reinforce focus on inhalation micronized APIs,” with the aim of tripling its production capacity by 2024.… Read more . . .
-
UK-based CDMO Upperton Pharma Solutions has launched a nasal delivery development platform called UpperNose, the company said. The UpperNose services include pre-formulation analyses, dosage form selection, and formulation and process development through to clinical trial… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal